News

Baltimore, MD (March 15, 2013) Neurofibromatosis Therapeutic Acceleration Program (NTAP) today announced a request for proposals (RFP) for the development of Patient Reported Outcome (PRO) measures that can be used to support clinical development of […]

Baltimore, MD (January 15, 2013) Neurofibromatosis Therapeutic Acceleration Program (NTAP) today announced the launch of an idea challenge for the development of biomarkers for neurofibromatosis type 1 (NF1)-associated plexiform neurofibromas (pNF). Individuals with pNF can […]

[vc_row][vc_column][vc_column_text margin_bottom=”10″]Baltimore, MD (October 1, 2012) Neurofibromatosis Therapeutic Acceleration Program (NTAP) today announced a request for proposals (RFP) for the development of novel cell culture models for neurofibromatosis type 1 (NF1)-associated plexiform neurofibromas (pNF). Cell […]

[vc_row][vc_column][vc_column_text margin_bottom=”10″]Baltimore, MD (September 22, 2012) Neurofibromatosis Therapeutic Acceleration Program (NTAP) held its inaugural Plexiform Neurofibroma Scientific Summit on September 20-22, 2012. Held at Nemacolin Woodlands Resort, the summit focused on defining existing resources and […]

[vc_row][vc_column][vc_column_text margin_bottom=”10″]Baltimore, MD (June 8, 2012) Today, the Neurofibromatosis Therapeutic Acceleration Program (NTAP) announced the launch of its operations, dedicated to improving treatment options for individuals with plexiform neurofibromas (pNFs). NTAP is a non-profit organization […]